Press Releases

Press Releases

Strong revenue growth and successful early launch of new HD-X Analyzer | November 06, 2019
Billerica, Mass.
October 25, 2019
Findings by leading researchers demonstrate the promise and relevance of Simoa in vast application areas.
October 22, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will release its financial results for third quarter 2019
Winners of the second annual call for research proposals focuses on predictive biomarkers of neurodegeneration, neurological injury and inflammation in relation to cognitive functioning and brain connectivity among breast cancer survivors | October 03, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--
Presentations by leading researchers demonstrate promise and relevance of Neurofilament light chain (Nf-L) as a reliable disease biomarker for MS | September 18, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--
Record-breaking number of presentations and abstracts at International Multiple Sclerosis conference demonstrates promise and relevance of Neurofilament light chain (Nf-L) as a reliable disease biomarker for MS | September 11, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--
August 13, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the closing of its previously announced underwritten public offe
August 09, 2019
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the pricing of its previously announced underwritten public offe
August 07, 2019
August 07, 2019 04:23 PM Eastern Daylight Time